InspireMD, Inc. appointed Alan W. Milinazzo as President, Chief Executive Officer, and a member of the board, effective January 3, 2013. He replaces Ofir Paz who previously announced his intention to step down as Chief Executive Officer in September 2012 once a successor was named. Mr. Paz will continue to serve as a director.

Mr. Milinazzo brings fifteen years of experience in interventional cardiology to bear on InspireMD's commercial strategy and operations as it launches a major new embolic protection stent technology platform, initially for patients undergoing emergency coronary intervention for potentially fatal heart attacks. Mr. Milinazzo most recently served as President and Chief Executive Officer of Orthofix International, a position he was promoted to in 2006 after being hired a year earlier as Chief Operating Officer.